Related Experiment Videos
The nurse's role in caring for patients undergoing LDL-Apheresis
Insights
LDL-Apheresis is a novel treatment removing harmful Low Density Lipoprotein (LDL) to prevent accelerated coronary artery disease post-cardiac transplant. This advanced therapy utilizes computerised technology and enhances patient care through skilled nursing communication.
Area of Science:
- Cardiovascular Medicine
- Medical Technology
Background:
- Coronary artery disease risk increases significantly after cardiac transplantation.
- Low Density Lipoprotein (LDL) is a key contributor to accelerated atherosclerosis.
- Current treatments for managing post-transplant cardiovascular complications are limited.
Purpose of the Study:
- To investigate the efficacy of LDL-Apheresis as a novel treatment for managing cardiovascular risk in cardiac transplant recipients.
- To explore the integration of advanced computerised technology in patient care.
- To highlight the evolving role of nursing in managing patients undergoing innovative medical treatments.
Main Methods:
- LDL-Apheresis, a highly computerised procedure, was employed to selectively remove LDL from patient circulation.
- The study focused on patients who had undergone cardiac transplantation.
- Nursing care strategies were adapted to incorporate advanced technology and enhance patient communication.
Main Results:
- LDL-Apheresis effectively removes harmful lipoproteins, specifically LDL.
- The treatment is associated with a reduction in accelerated coronary artery disease risk.
- The implementation of this technology created new opportunities for nursing skill development, particularly in communication.
Conclusions:
- LDL-Apheresis represents a promising, technologically advanced treatment for mitigating cardiovascular risk in cardiac transplant patients.
- The integration of such technologies necessitates an adaptive and skilled nursing approach.
- Enhanced patient-nurse communication is crucial for optimizing care during innovative treatments.
Abstract:
LDL-Apheresis is a new, exciting, highly computerised treatment which is currently being researched. It selectively removes the harmful lipoproteins, in particular Low Density Lipoprotein (LDL) to which is attributed accelerated coronary artery disease 2-3 years after cardiac transplantation. Accepting the rather unique nursing role caring for patients receiving this treatment, the author has found that the research programme has opened up a challenging and very interesting variation in her career using advanced computerised technology. But it has also provided increased opportunity for her to use nursing skills, particularly in the area of communication, to enhance her relationship with the patients and raise the standard of care given.